Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing an Improved Measure of Chemosensitivity for the Study of Periodic Breathing in Heart Failure: the Cyclocapnic Method

NCT01049256 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01049256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01049256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing an Improved Measure of Chemosensitivity for the Study of Periodic Breathing in Heart Failure: the Cyclocapnic Method
Lead sponsor
Imperial College London
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2008
Completion date
October 31, 2010
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, periodic breathing